The value of the Advanced Lung Cancer Inflammation Index (ALI) in assessing the prognosis of patients with hepatocellular carcinoma treated with camrelizumab: a retrospective cohort study

BACKGROUND: The Advanced Lung Cancer Inflammation Index (ALI) is considered a useful prognostic biomarker for clinical outcome in patients with malignancy. However, the prognostic value of ALI in patients with advanced hepatocellular carcinoma (HCC) is unclear. In this study we assessed the prognost...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qian, Ma, Fei, Tsilimigras, Diamantis I., Åberg, Fredrik, Wang, Ju Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761123/
https://www.ncbi.nlm.nih.gov/pubmed/36544677
http://dx.doi.org/10.21037/atm-22-5099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761123/
https://www.ncbi.nlm.nih.gov/pubmed/36544677
http://dx.doi.org/10.21037/atm-22-5099

Ejemplares similares